Chemical Biology & Drug Design · 2017 · 19 citations · 15 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsCholinergic PharmacologyEnzyme InhibitionLead Compound DesignLigand BindingLigand-based DesignStructure-activity Relationship AnalysisAcetylcholinesterase InhibitorsBiological Evaluation ReportChemical Synthesis Of AnaloguesInhibitory NeurotransmissionMedicinal Chemistry Applications
A series of novel 4‐isochromanone compounds bearing N ‐benzyl pyridinium moiety were designed and synthesized as acetylcholinesterase ( AC hE) inhibitors. The biological evaluation showed that most of the target compounds exhibited potent inhibitory activities against AC hE. Among them, compound 1q possessed the strongest anti‐ AC hE activity with an IC 50 value of 0.15 n m and high AC hE/BuChE selectivity ( SI > 5,000). Moreover, compound 1q had low toxicity in normal nerve cells and was relatively stable in rat plasma. Together, the current finding may provide a new approach for the discovery of novel anti‐Alzheimer's disease agents.
15
Rangappa S. Keri, Catarina Quintanova, Sérgio M. Marques et al. · Bioorganic & Medicinal Chemistry · 2013 · 107 citations · Full text